TNNI3 overexpression was commonly observed in various solid tumors and involved in the progression and metastasis of ovarian cancer (Salvesen and Trovik, 2011; Chen et al., 2014; Yang et al., 2017; Yin et al., 2021). Here, TNNI3 is linked to ovarian carcinoma.